TRAW 8-K 2026-10-23

Traws Pharma, Inc. (TRAW) 8-K dated 2026-10-23 — accession 0001104659-26-118519. This URL is the filing, not the TRAW hub.

Traws Pharma, Inc. (TRAW) is a biotechnology company listed on NASDAQ.

Traws Pharma, Inc. filed a 8-K on 2026-10-23. Accession 0001104659-26-118519.

Cached items: 1.01, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was -$4.0M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.

Not investment advice. The TRAW SEC hub lists recent forms. The stock page is the research view.